Khalaf Michel's Form 4 filing
Metlife IncMET · filed Nov 12, 2026
- Accession no.
- 0001535491-26-000007
- Filed
- Nov 12, 2026, 4:23 PM ET
- Trade date
- Nov 10, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $19.3M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Khalaf MichelCIK 0001535491 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Common Stock | MOption exerciseAcquired | +28,817 | $46.85 | +$1,350,076.45 | 726,526 | Direct | |
| Nov 10, 2026 | Common Stock | MOption exerciseAcquired | +34,608 | $45.50 | +$1,574,664 | 761,134 | Direct | |
| Nov 10, 2026 | Common Stock | MOption exerciseAcquired | +90,726 | $44.65 | +$4,050,915.9 | 851,860 | Direct | |
| Nov 10, 2026 | Common Stock | MOption exerciseAcquired | +94,578 | $47.58 | +$4,500,021.24 | 946,438 | Direct | |
| Nov 10, 2026 | Common Stock | SSaleDisposed | −187,425 | $102.97F2 | −$19,298,702.43 | 759,013 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Common Stock | MOption exerciseDisposed | −28,817 | $0.00 | $0 | 0 | Direct | |
| Nov 10, 2026 | Common Stock | MOption exerciseDisposed | −34,608 | $0.00 | $0 | 0 | Direct | |
| Nov 10, 2026 | Common Stock | MOption exerciseDisposed | −90,726 | $0.00 | $0 | 0 | Direct | |
| Nov 10, 2026 | Common Stock | MOption exerciseDisposed | −94,578 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $102.59 to $103.235, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.